Abbott AxSYM Immunoassay System
Abbott AxSYM Immunoassay System
| Product Description |
The Abbott AxSYM Immunoassay System is designed to meet the accuracy and precision requirements of clinical laboratories. Capable of running 80 up to 120 tests per hour, this Abbott immunoassay analyzer system handles applications for medium volume clinical laboratories.
The AxSYM system enables the simultaneous performance of various immunodiagnostic tests, and the addition of tests during runs. This Abbott immunoassay analyzer uses three technologies, namely fluorescence polarization immunoassay, microparticle enzyme immunoassay and the new ion-capture immunoassay.
As the third-generation immunoassay system, the AxSYM immunoassay analyzer combines continuous access, random access, and STAT processing with a menu for broad testing.
Call us today to learn more about the Abbott AxSYM Immunoassay System!
| AxSYM Immunoassay System | |
| System | Closed System |
| Tests | Processes up to 120 tests/hr |
| Throughput | 80 to 120 tests per hour |
| Uses | Serology Test Therapeutic Drug Monitoring Hormone level Some cardiac markers (Troponin) |
| Method | Uses antibodies to alter the deflection of polarized light |
| Technology | Microparticle enzyme immunoassay (MEIA), fluorescence polarization immunoassay (FIA), and ion-capture immunoassay |
| Dimensions | |
| H x W x D | 64 x 67 x 37 (in) 152 x 160 x 84 (cm) |
| Weight | 661 lbs (300 kg) |
| PC/Software | Version 6.0 |
| AbbottLink® Data Accessibility: Allows Customer Support Organization the ability to retrieve AxSYM QC data more efficiently | |
| Enhanced Printer Capability: Improve flexibility by providing the option to configure AxSYM SW to use other printers | |
| Solution 2 Pump Enhancement: Improve AxSYM reliability by providing the capability to disable the Bulk 2 pump if Ion Capture assays are not installed | |
| AxSYM/ARCHITECT Common Carrier Software: Supports the AxSYM/ARCHITECT Common Carrier* | |
| Monitor Option: Provides flexibility for future monitor replacement | |
| Host: Improves productivity by reducing Host Log size from 15K to 5K | |
| Details | Continuous access |
| Random access | |
| STAT processing with a broad testing menu | |
| In-line pressure monitoring | |
| Foam avoidance | |
| Enhanced Exception Management | |
| Ratio calculation | |
| STAT rerun capabilities | |
| Exterior hardware enhancements | |
| Tests | Tests 47 analytes in the the following categories: |
| CancerAFP | |
| CA 125 | |
| CA 15-3 | |
| CA 19-9 | |
| CEA | |
| Free PSA | |
| Total PSA | |
| Fertility/Pregnancy, | |
| CardiacBNP | |
| CK-MB | |
| D-Dimer | |
| Myoglobin | |
| Troponin-I | |
| Drugs of Abuse/ToxicologyAcetaminophen | |
| Amphetamine/ Methamphetamine | |
| Barbiturates II U | |
| Benzodiazepines | |
| Cannabinoids | |
| Cocaine Metabolite | |
| Methadone | |
| Opiates | |
| Phencyclidine (PCP) | |
| REA Ethanol | |
| Salicylate | |
| Tricyclic Antidepressants | |
| Fertility/PregnancyEstradiol | |
| FSH | |
| hCG (Total B-hCG) | |
| LH | |
| Progesterone | |
| Prolactin | |
| Testosterone | |
| Infectious Disease Congenitals | |
| CMV IgG | |
| CMV IgM | |
| Rubella IgG | |
| Rubella IgM | |
| TOXO IgG | |
| TOXO IgM | |
| Hepatitis | |
| Anti-HAV IgM | |
| Anti-HAV Total | |
| Anti-HBc | |
| Anti-HBc IgM | |
| Anti-HBs | |
| Anti-HCV | |
| HBe | |
| HBsAg | |
| HBsAg Confirmatory | |
| Retrovirus | |
| Anti-HIV-1/HIV-2 | |
| HIV Ag/Ab Combo | |
| MetabolicActive-B12 (HoloTC) | |
| Anti-CCP | |
| B12 | |
| Beta2 Microglobulin | |
| Cortisol | |
| Ferritin | |
| Folate | |
| Glycated Hemoglobin | |
| Homocysteine | |
| Insulin | |
| Therapeutic Drug Monitoring Carbamazepine | |
| Digitoxin | |
| Digoxin | |
| Gentamicin | |
| N-Acetyl-procainamide | |
| Phenobarbital | |
| Phenytoin | |
| Procainamide | |
| Quinidine | |
| Theophylline | |
| Tobramycin | |
| Valproic Acid | |
| Vancomycin | |
| Thyroid3rd Gen TSH | |
| Anti-Tg | |
| Anti-TPO | |
| Free T3 | |
| Free T4 | |
| T-Uptake | |
| Total T3 | |
| Total T4 | |
| Ultrasensitive hTSH II | |
| Transplant | |
| Cyclosporine | |

